Showing results (291-300 of 324) with videos related to
Sort By:
Pageof 33
BMC Cancer|May 18, 2019
Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancerFeng Wang, Ming-Ming He, Zi-Xian Wang, et al.Hepatology (Baltimore, Md.)|March 12, 2014
Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expressionDong-Liang Chen, Zhi-Qiang Wang, Zhao-Lei Zeng, et al.Clinical and Translational Medicine|September 23, 2023
Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cellsJiaojiao Yang, Liyue Sun, Xiao-Yun Liu, et al.Gut|September 7, 2021
Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatmentFeng Wang, You-Sheng Huang, Hao-Xiang Wu, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 12, 2024
Percutaneous hepatic artery infusion chemotherapy with oxaliplatin and fluoropyrimidines in treatment-resistant colorectal cancer patients with unresectable liver metastases: a retrospective cohort studyWilliam Pat Fong, Zi-Jing Li, Chao Ren, et al.Cancer|June 23, 2017
Efficacy and safety of recombinant human lymphotoxin-α derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trialFeng-Hua Wang, Yun Wang, Guo-Ping Sun, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 6, 2022
Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNALiu-Fang Ye, Zi-Yao Huang, Xiao-Xi Chen, et al.Plos One|March 7, 2014
Patients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancerXiao-li Wei, Miao-zhen Qiu, Huan-xin Lin, et al.Chinese Journal of Cancer|January 16, 2016
Expert consensus on maintenance treatment for metastatic colorectal cancer in ChinaRui-Hua Xu, Lin Shen, Jin Li, et al.Biomolecules|September 28, 2021
The Prognostic Value of Locoregional Interventions for BRAF V600E Metastatic Colorectal Cancer: A Retrospective Cohort AnalysisLiu-Fang Ye, Xiao-Meng Ji, Chao Ren, et al.Pageof 33